232 related articles for article (PubMed ID: 15240672)
1. FTY720-enhanced T cell homing is dependent on CCR2, CCR5, CCR7, and CXCR4: evidence for distinct chemokine compartments.
Yopp AC; Fu S; Honig SM; Randolph GJ; Ding Y; Krieger NR; Bromberg JS
J Immunol; 2004 Jul; 173(2):855-65. PubMed ID: 15240672
[TBL] [Abstract][Full Text] [Related]
2. FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes.
Honig SM; Fu S; Mao X; Yopp A; Gunn MD; Randolph GJ; Bromberg JS
J Clin Invest; 2003 Mar; 111(5):627-37. PubMed ID: 12618517
[TBL] [Abstract][Full Text] [Related]
3. CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720.
Henning G; Ohl L; Junt T; Reiterer P; Brinkmann V; Nakano H; Hohenberger W; Lipp M; Förster R
J Exp Med; 2001 Dec; 194(12):1875-81. PubMed ID: 11748287
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine 1-phosphate receptors regulate chemokine-driven transendothelial migration of lymph node but not splenic T cells.
Yopp AC; Ochando JC; Mao M; Ledgerwood L; Ding Y; Bromberg JS
J Immunol; 2005 Sep; 175(5):2913-24. PubMed ID: 16116177
[TBL] [Abstract][Full Text] [Related]
5. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
Chiba K; Matsuyuki H; Maeda Y; Sugahara K
Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
[TBL] [Abstract][Full Text] [Related]
6. The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells.
Kimura T; Boehmler AM; Seitz G; Kuçi S; Wiesner T; Brinkmann V; Kanz L; Möhle R
Blood; 2004 Jun; 103(12):4478-86. PubMed ID: 14988150
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells.
Xie JH; Nomura N; Koprak SL; Quackenbush EJ; Forrest MJ; Rosen H
J Immunol; 2003 Apr; 170(7):3662-70. PubMed ID: 12646631
[TBL] [Abstract][Full Text] [Related]
8. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L-positive T cells in Peyer's patches by FTY720-induced lymphocyte homing.
Yanagawa Y; Masubuchi Y; Chiba K
Immunology; 1998 Dec; 95(4):591-4. PubMed ID: 9893050
[TBL] [Abstract][Full Text] [Related]
9. FTY720 treatment of kidney transplant patients: a differential effect on B cells, naïve T cells, memory T cells and NK cells.
Vaessen LM; van Besouw NM; Mol WM; Ijzermans JN; Weimar W
Transpl Immunol; 2006 Apr; 15(4):281-8. PubMed ID: 16635750
[TBL] [Abstract][Full Text] [Related]
10. The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches.
Halin C; Scimone ML; Bonasio R; Gauguet JM; Mempel TR; Quackenbush E; Proia RL; Mandala S; von Andrian UH
Blood; 2005 Aug; 106(4):1314-22. PubMed ID: 15870184
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.
Taylor JR; Kimbrell KC; Scoggins R; Delaney M; Wu L; Camerini D
J Virol; 2001 Sep; 75(18):8752-60. PubMed ID: 11507220
[TBL] [Abstract][Full Text] [Related]
12. The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo.
Lan YY; De Creus A; Colvin BL; Abe M; Brinkmann V; Coates PT; Thomson AW
Am J Transplant; 2005 Nov; 5(11):2649-59. PubMed ID: 16212624
[TBL] [Abstract][Full Text] [Related]
13. FTY720 exerts differential effects on CD4+ and CD8+ T-lymphocyte subpopulations expressing chemokine and adhesion receptors.
Böhler T; Waiser J; Schuetz M; Neumayer HH; Budde K
Nephrol Dial Transplant; 2004 Mar; 19(3):702-13. PubMed ID: 14767029
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
[TBL] [Abstract][Full Text] [Related]
15. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.
Mehling M; Brinkmann V; Antel J; Bar-Or A; Goebels N; Vedrine C; Kristofic C; Kuhle J; Lindberg RL; Kappos L
Neurology; 2008 Oct; 71(16):1261-7. PubMed ID: 18852441
[TBL] [Abstract][Full Text] [Related]
16. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity.
Sawicka E; Dubois G; Jarai G; Edwards M; Thomas M; Nicholls A; Albert R; Newson C; Brinkmann V; Walker C
J Immunol; 2005 Dec; 175(12):7973-80. PubMed ID: 16339533
[TBL] [Abstract][Full Text] [Related]
17. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
[TBL] [Abstract][Full Text] [Related]
18. Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats.
Schaier M; Vorwalder S; Sommerer C; Dikow R; Hug F; Gross ML; Waldherr R; Zeier M
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F769-80. PubMed ID: 19535570
[TBL] [Abstract][Full Text] [Related]
19. Enhanced FTY720-mediated lymphocyte homing requires G alpha i signaling and depends on beta 2 and beta 7 integrin.
Pabst O; Herbrand H; Willenzon S; Worbs T; Schippers A; Müller W; Bernhardt G; Förster R
J Immunol; 2006 Feb; 176(3):1474-80. PubMed ID: 16424175
[TBL] [Abstract][Full Text] [Related]
20. Distinct properties of circulating CD8+ T cells in FTY720-treated patients with multiple sclerosis.
Johnson TA; Lapierre Y; Bar-Or A; Antel JP
Arch Neurol; 2010 Dec; 67(12):1449-55. PubMed ID: 21149809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
